jueves, 4 de octubre de 2018

New project identifies immune checkpoint inhibition as potential treatment for angiosarcomas

New project identifies immune checkpoint inhibition as potential treatment for angiosarcomas



 
 October 4, 2018 
 Immunology 
 The latest immunology news from News Medical 
 #ALT#Save 15% on Immuno-oncology Primary Antibodies from Abcam

Try a RabMAb rabbit monocolonal primary antibody in your lab and see for yourself how RabMAb antibodies offer you superior specificity and reproducibility.

Get Your Discount
 
 
  KeysightA Single Platform to Sequence All Monoclonal Antibody Proteins
 
Having a single platform to sequence all monoclonal antibody proteins provides researchers with the important pieces of information they need to know at an early stage of antibody drug discovery, research and development processes. 
 
Learn More
 
 
   New type of fatty acid can slow down overreactive immune systemNew type of fatty acid can slow down overreactive immune system
 
Sometimes, the body's otherwise intelligent immune system mistakenly attacks the body's healthy tissue by responding to infections that do not exist.
 
 Scientists better understand influenza virus and how it spreads
 
Scientists better understand influenza virus and how it spreadsThe seasonal flu is caused by different subtypes of Influenza A virus and typically leads to the death of half a million people each year.
 
 
 Scientists predict how well the body will fight lung cancer by analyzing immune cell shapes
 
Scientists predict how well the body will fight lung cancer by analyzing immune cell shapesResearchers at Case Western Reserve University have discovered how to quickly and accurately predict which lung cancer patients will benefit from chemotherapy by analyzing how immune cells the body sends out to fight the disease are arranged.
 
 
 Overlooked immune cells could play a key role in cancer immunotherapy, claims new study
 
Overlooked immune cells could play a key role in cancer immunotherapy, claims new studyCancer immunotherapy is a relatively new method of treating cancer and has succeeded with some refractory tumors. However, it doesn’t always work, why not?
 
 
 New project identifies immune checkpoint inhibition as potential treatment for angiosarcomas
 
New project identifies immune checkpoint inhibition as potential treatment for angiosarcomasAngiosarcoma Project, a patient-partnered genomics study, identified immune checkpoint inhibition as a potential treatment option for patients with angiosarcomas of the head, face, neck, or scalp, according to data presented at the fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference.
 
 
 Immune protein 'flutters' like a butterfly in search of viruses, finds study
 
Immune protein 'flutters' like a butterfly in search of viruses, finds studyResearchers at Rutgers Robert Wood Johnson Medical School have identified an important step in the process that allows our bodies to fight viruses.
 

No hay comentarios:

Publicar un comentario